Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty
Clinical trial NCT03169231 · COMPLETED
Trial details
- NCT number
- NCT03169231
- Sponsor
- Longeveron Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-06
- Primary completion
- 2021-09-30
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.